cervical dystonia
CERVICAL DYSTONIA : A CURRENT REVIEW
7
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)
7
Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms
11
Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD)
8
The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?
9
<p>Benefits, Safety, and Adjunct Modality Prevalences of Long-Term Botulinum Toxin Injections for Cervical Dystonia and Myofascial Neck Pain: A Retrospective Cohort Study</p>
8
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
6
Cervical dystonia: a disorder of the midbrain network for covert attentional orienting
10
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
6
Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A
7
A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom
9
A Case of Posttraumatic Cervical Dystonia Treated with OnabotulinumtoxinA
6
Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
9
Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial
8
Botulinum toxin type A in the treatment of patients with cervical dystonia
8
Exploring factors related to physical activity in cervical dystonia
8
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headacheReport of the Guideline Development Subcommittee of the American Academy of Neurology
11
Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia
8
Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms
7
Clinical and genetic features of cervical dystonia in a large multicenter cohort
13